Glyxambi 25 mg/1 (Empagliflozin and Linagliptin TABLET, FILM COATED) 25 mg/1

Glyxambi 25 mg/1 is a combination medication containing empagliflozin and linagliptin, used to manage type 2 diabetes. This oral tablet helps control blood sugar levels and is available in a 90-tablet bottle.

Strength

25 mg/1

Pack Size

90 TABLET, FILM COATED in 1 BOTTLE (0597-0164-90)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glyxambi 25 mg/1 is primarily used to manage type 2 diabetes by improving blood sugar control. Empagliflozin works by helping the kidneys remove excess glucose from the body, while linagliptin helps the pancreas produce more insulin. This combination can be part of a broader diabetes management plan, including diet and exercise.

Side Effects

Common effects of Glyxambi 25 mg/1 may include urinary tract infections, genital fungal infections, and low blood sugar when combined with other diabetes medications. Some users may also experience headaches, dizziness, or gastrointestinal discomfort. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Glyxambi 25 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It is important to stay hydrated and monitor blood sugar levels regularly. Always follow the guidance of a healthcare professional when starting or adjusting any medication.

Avoid Interactions

Glyxambi 25 mg/1 may interact with other medications, including insulin, other diabetes drugs, and certain antibiotics. Alcohol and some over-the-counter medications can also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

Glyxambi 25 mg/1 is used to manage type 2 diabetes by improving blood sugar control through a combination of empagliflozin and linagliptin.

Glyxambi 25 mg/1 should be stored at room temperature, away from moisture and heat. Keep the bottle tightly closed when not in use.

Yes, Glyxambi 25 mg/1 can cause low blood sugar, especially when combined with other diabetes medications. Monitor blood sugar levels regularly.

Common side effects include urinary tract infections, genital fungal infections, headaches, dizziness, and gastrointestinal discomfort.

Glyxambi 25 mg/1 may not be suitable for everyone, especially those with kidney issues or a history of pancreatitis. Consult a healthcare provider before use.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.